BMJ:抗生素耐药性所导致的不良影响将超过医疗对寿命的改善

2016-05-20 sunshine 译 MedSci原创

BMJ研究新闻:抗生素耐药性感染所致的死亡人数正不断增加据抗菌素耐药性的报道显示,在美国和欧洲每年有50000人死于抗生素耐药性感染,且在未来十年这一人数可能还会增加。英国精算师协会发表的Longevity Bulletin on Antimicrobial Resistance分析了当前抗生素耐药性的趋势对未来10年英国及OECD国家人们预期寿命的影响。原始出处:Susan Mayor. Inc

据抗菌素耐药性的报道显示,在美国和欧洲每年有50000人死于抗生素耐药性感染,且在未来十年这一人数可能还会增加。

英国精算师协会发表的Longevity Bulletin on Antimicrobial Resistance分析了当前抗生素耐药性的趋势对未来10年英国及OECD国家人们预期寿命的影响。

基于现有的研究发现,该报道作者认为,未来十年感染性疾病相关的死亡率将增加至1951年死亡率的一半左右,相当于到2025年,感染性疾病的死亡率达到0.5‰左右,对应于每年死亡率增加0.2-0.3%。

报告中警告道,抗生素耐药性也会影响从大型手术中恢复的患者以及接受化疗的患者的死亡率,使得总死亡率每年增加2-3%左右。

基于医学专家小组的建议,研究人员将此结果与寿命的预期增加以及健康支出和社会因素(如吸烟,预计每年增加1%左右)的影响进行了对比。

该研究作者,Willis Towers Watson公司的资深风险管理顾问,Matthew Edwards说道,“这很显而易见,抗生素耐药性增加导致的死亡率增加可能与寿命的增加相同甚至是超过。”

英国医疗总监Sally Davies在报告的前言中写道,“我们已经看到了抗菌素耐药性所导致的后果,在欧洲和美国每年因抗生素耐药性感染致50000人死亡,放眼全球这个数目会更大。“

“预计未来的死亡人数更令人担忧。目前这个时代物质死亡率的改善将让位于多年物质死亡率的恶化。”

Davies指出,“为了解决这个问题,在英国我们寻求一种多层次的方法。在一些领域,从医院卫生和畜牧业到医药投资和疫苗接种计划,正在紧急采取行动,但是需要国际一期应用才可保证这些行动的有效性。”

原始出处:

Susan Mayor. Increase in deaths from antibiotic resistant infections may limit rising longevity, report warns. BMJ 2016; 353 doi: http://dx.doi.org/10.1136/bmj.i2845.

Institute and Faculty of Actuaries. Longevity bulletin: antimicrobial resistance. May 2016.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1848003, encodeId=e95c184800330, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat Dec 24 17:03:00 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441625, encodeId=4c791441625e7, content=<a href='/topic/show?id=64655544106' target=_blank style='color:#2F92EE;'>#抗生素耐药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55441, encryptionId=64655544106, topicName=抗生素耐药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cac4876897, createdName=12498bf3m26暂无昵称, createdTime=Sun May 22 06:03:00 CST 2016, time=2016-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604445, encodeId=491a16044455b, content=<a href='/topic/show?id=13235544294' target=_blank style='color:#2F92EE;'>#抗生素耐药性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55442, encryptionId=13235544294, topicName=抗生素耐药性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69fc19187130, createdName=liuyg0234, createdTime=Sun May 22 06:03:00 CST 2016, time=2016-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86766, encodeId=e6b386e667b, content=慎用抗生素, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sat May 21 14:57:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86762, encodeId=683f86e622b, content=或许人类将进入后抗生素时代, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/9EAA00AA9ACAB769080214A22CA92FFD/100, createdBy=add81726939, createdName=QQ2830df40, createdTime=Sat May 21 14:44:00 CST 2016, time=2016-05-21, status=1, ipAttribution=)]
    2016-12-24 gaoxiaoe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1848003, encodeId=e95c184800330, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat Dec 24 17:03:00 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441625, encodeId=4c791441625e7, content=<a href='/topic/show?id=64655544106' target=_blank style='color:#2F92EE;'>#抗生素耐药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55441, encryptionId=64655544106, topicName=抗生素耐药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cac4876897, createdName=12498bf3m26暂无昵称, createdTime=Sun May 22 06:03:00 CST 2016, time=2016-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604445, encodeId=491a16044455b, content=<a href='/topic/show?id=13235544294' target=_blank style='color:#2F92EE;'>#抗生素耐药性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55442, encryptionId=13235544294, topicName=抗生素耐药性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69fc19187130, createdName=liuyg0234, createdTime=Sun May 22 06:03:00 CST 2016, time=2016-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86766, encodeId=e6b386e667b, content=慎用抗生素, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sat May 21 14:57:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86762, encodeId=683f86e622b, content=或许人类将进入后抗生素时代, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/9EAA00AA9ACAB769080214A22CA92FFD/100, createdBy=add81726939, createdName=QQ2830df40, createdTime=Sat May 21 14:44:00 CST 2016, time=2016-05-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1848003, encodeId=e95c184800330, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat Dec 24 17:03:00 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441625, encodeId=4c791441625e7, content=<a href='/topic/show?id=64655544106' target=_blank style='color:#2F92EE;'>#抗生素耐药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55441, encryptionId=64655544106, topicName=抗生素耐药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cac4876897, createdName=12498bf3m26暂无昵称, createdTime=Sun May 22 06:03:00 CST 2016, time=2016-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604445, encodeId=491a16044455b, content=<a href='/topic/show?id=13235544294' target=_blank style='color:#2F92EE;'>#抗生素耐药性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55442, encryptionId=13235544294, topicName=抗生素耐药性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69fc19187130, createdName=liuyg0234, createdTime=Sun May 22 06:03:00 CST 2016, time=2016-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86766, encodeId=e6b386e667b, content=慎用抗生素, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sat May 21 14:57:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86762, encodeId=683f86e622b, content=或许人类将进入后抗生素时代, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/9EAA00AA9ACAB769080214A22CA92FFD/100, createdBy=add81726939, createdName=QQ2830df40, createdTime=Sat May 21 14:44:00 CST 2016, time=2016-05-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1848003, encodeId=e95c184800330, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat Dec 24 17:03:00 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441625, encodeId=4c791441625e7, content=<a href='/topic/show?id=64655544106' target=_blank style='color:#2F92EE;'>#抗生素耐药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55441, encryptionId=64655544106, topicName=抗生素耐药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cac4876897, createdName=12498bf3m26暂无昵称, createdTime=Sun May 22 06:03:00 CST 2016, time=2016-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604445, encodeId=491a16044455b, content=<a href='/topic/show?id=13235544294' target=_blank style='color:#2F92EE;'>#抗生素耐药性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55442, encryptionId=13235544294, topicName=抗生素耐药性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69fc19187130, createdName=liuyg0234, createdTime=Sun May 22 06:03:00 CST 2016, time=2016-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86766, encodeId=e6b386e667b, content=慎用抗生素, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sat May 21 14:57:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86762, encodeId=683f86e622b, content=或许人类将进入后抗生素时代, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/9EAA00AA9ACAB769080214A22CA92FFD/100, createdBy=add81726939, createdName=QQ2830df40, createdTime=Sat May 21 14:44:00 CST 2016, time=2016-05-21, status=1, ipAttribution=)]
    2016-05-21 忠诚向上

    慎用抗生素

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1848003, encodeId=e95c184800330, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat Dec 24 17:03:00 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441625, encodeId=4c791441625e7, content=<a href='/topic/show?id=64655544106' target=_blank style='color:#2F92EE;'>#抗生素耐药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55441, encryptionId=64655544106, topicName=抗生素耐药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cac4876897, createdName=12498bf3m26暂无昵称, createdTime=Sun May 22 06:03:00 CST 2016, time=2016-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604445, encodeId=491a16044455b, content=<a href='/topic/show?id=13235544294' target=_blank style='color:#2F92EE;'>#抗生素耐药性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55442, encryptionId=13235544294, topicName=抗生素耐药性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69fc19187130, createdName=liuyg0234, createdTime=Sun May 22 06:03:00 CST 2016, time=2016-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86766, encodeId=e6b386e667b, content=慎用抗生素, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sat May 21 14:57:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86762, encodeId=683f86e622b, content=或许人类将进入后抗生素时代, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/9EAA00AA9ACAB769080214A22CA92FFD/100, createdBy=add81726939, createdName=QQ2830df40, createdTime=Sat May 21 14:44:00 CST 2016, time=2016-05-21, status=1, ipAttribution=)]
    2016-05-21 QQ2830df40

    或许人类将进入后抗生素时代

    0

相关资讯

Elife:古生菌或可作为抗菌药来源

目前,最神秘的一种生命形式,被证明可能是一种丰富和尚未开发的抗菌药来源。这种神秘的生命形式就是古生菌(Archaea),是一个单细胞生物家族,生长在极端环境,例如沸腾的热液池和冒着烟的深海喷口,对于大多数其他物种来说,这些条件都过于极端。 美国范德堡大学生物科学副教授Seth Bordenstein带领了这项研究,他指出:“这是首次在古生菌中发现功能性的抗菌基因。你不能夸大人类

WHO调查揭示公众对抗生素耐药性问题普遍存在误解

015年11月16日 ¦ 日内瓦 - 正当世界卫生组织(世卫组织)加大力度对付抗生素耐药性问题时,一份新的多国调查显示人们对这一重大公众健康威胁存在困惑,不知道如何能防止其加剧。 抗生素耐药性系指细菌发生变化,对用以治疗由其引起的感染的抗生素产生耐药力。过度使用和滥用抗生素会增加耐药菌的发展,这项调查指出某些做法、认识空白以及误解都在助长这种现象。 在12个国家接受调查的约